- American City Business Journals•last month
It's been a big month for D.C.-based Vanda Pharmaceuticals Inc. Only a few weeks ago, Vanda (VNDA) received Food and Drug Administration approval to expand the use of its lead drug Fanapt as a maintenance treatment for schizophrenia in adults. Then on Wednesday, Vanda announced the FDA also granted three years of marketing exclusivity for the drug.
- Insider Monkey•last month
Fading chances of a rate hike soothed the market sentiment on Wednesday. Some important stocks which are making headlines today, include Vornado Realty Trust (NYSE:VNO), Panera Bread Co (NASDAQ:PNRA), Cisco Systems, Inc. (NASDAQ:CSCO), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA). Let’s see why these stocks are on the move today and what the funds we […]
Vanda Pharmaceuticals, Inc.NasdaqGM
After hours: 11.210.00 (0.00%) as of 5:01 PM EDT
|Bid||10.60 x 1000|
|Ask||11.69 x 100|
|52wk Range||6.91 - 14.50|
|Day's Range||11.18 - 11.41|
|Avg Vol (3m)||604,874|
As of 4:00 PM EDT. Market closed.